The company’s net sales revenue rose to 14.9 million levs in the January-September period from 12.7 million levs a year earlier, Medica said in a filing with the Sofia bourse.
Net earnings per share rose to 0.17 levs in the period under review from 0.11 levs a year earlier.
Shares in Medica were last traded on the Bulgarian Stock Exchange on Monday, closing 9.37 lower at 2.0 levs.
(1 euro = 1.95583 Bulgarian levs)